Royce & Associates’s Intermolecular, Inc. IMI Stock Holding History

Royce & Associates’s Portfolio IMI Stock Details IMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-280,000	Closed	-$367K	–	1288
2018 Q1	$367K	Hold	280,000	–	–	﹤0.01%	1063
2017 Q4	$384K	Hold	280,000	–	–	﹤0.01%	1060
2017 Q3	$286K	Hold	280,000	–	–	﹤0.01%	1054
2017 Q2	$260K	Hold	280,000	–	–	﹤0.01%	1070
2017 Q1	$260K	Hold	280,000	–	–	﹤0.01%	1069
2016 Q4	$265K	Hold	280,000	–	–	﹤0.01%	1034
2016 Q3	$278K	Hold	280,000	–	–	﹤0.01%	1031
2016 Q2	$414K	Sell	280,000 -104,196	-27%	-$210K	﹤0.01%	1008
2016 Q1	$972K	Sell	384,196 -21,252	-5%	-$47.9K	0.01%	931
2015 Q4	$941K	Sell	405,448 -40,000	-9%	-$83.7K	0.01%	945
2015 Q3	$842K	Hold	445,448	–	–	﹤0.01%	985
2015 Q2	$878K	Hold	445,448	–	–	﹤0.01%	1039
2015 Q1	$731K	Hold	445,448	–	–	﹤0.01%	1054
2014 Q4	$860K	Buy	445,448 +121,448	+37%	+$258K	﹤0.01%	1098
2014 Q3	$752K	Hold	324,000	–	–	﹤0.01%	1167
2014 Q2	$755K	Sell	324,000 -98,000	-23%	-$245K	﹤0.01%	1179
2014 Q1	$1.18M	Buy	+422,000	New	+$1.54M	﹤0.01%	1128

Other funds holding IMI

RCM

Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return

SPM

Symmetry Peak Management Radnor, Pennsylvania $369M AUM 148.4% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Royce & Associates's IMI Position: Q2 2018 in Review

Royce & Associates sold out of Intermolecular, Inc. (IMI) in Q2 2018, closing a stake of 280,000 shares — an estimated $367K sold.

Royce & Associates first reported a position in IMI in Q1 2014 and held it in 17 quarters. The position peaked at $1.18M in Q1 2014. 25 funds tracked by Wall St. Rank hold IMI as of Q2 2018.

Royce & Associates reported no remaining Intermolecular, Inc. position as of Q2 2018 after selling out during the quarter.
Royce & Associates sold 280,000 Intermolecular, Inc. shares in Q2 2018, an estimated $367K.
Royce & Associates first reported a position in Intermolecular, Inc. in Q1 2014 and held it in 17 quarters.
Royce & Associates's Intermolecular, Inc. position peaked at $1.18M in Q1 2014.
25 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q2 2018.

Based on Royce & Associates's 13F filing for Q2 2018, filed 9 Aug 2018.